Symmetry Medical, Inc. (SMA): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

By
A A A

Summary:
We reaffirm our Neutral recommendation on Symmetry Medical. The company's 2014-first quarter earnings surged 75% to $0.07 but lagged the Zacks Consensus Estimate by $0.02. However, top line of $101.3 million rose 2.4% and beat the mark. The company's decision to divest U.K. based Clamonta will benefit in the long-run but negatively affect 2014 earnings and revenues. The new high-margin Surgical business continues to face headwinds, but we believe that long-term prospects of this business are still intact. New products, harmonized sales force and eventual accretion from acquired businesses should also bolster the company's growth going forward. We set a target of $9.25 on the stock.

Overview:

Symmetry Medical, Inc. (SMA), headquartered in Warsaw, Ind., was established in 1976 as an instruments supplier to orthopedic device manufacturers. The company went public in Dec 2004. The company is now the world's largest independent provider of implants and related instruments and cases to orthopedic device manufacturers.

Symmetry Medical also designs, develops, and produces for companies in other segments of the medical device market, including dental, osteobiologic, and endoscopy sectors, and provides limited specialized products and services to non-healthcare markets, such as the aerospace market. The company provides its customers with a broad range of products, comprehensive services, and production capabilities through its Total Solutions approach. Symmetry Medical markets its Total Solutions approach through its experienced sales force in the United States, Europe, and Japan.

Segments

Symmetry Medical operates in two reportable segments: (1) Original Equipment Manufacturer ("OEM") Solutions and (2) Symmetry Surgical.

Symmetry Medical's core Original Equipment Manufacturing (OEM) Solutions business (79.6% of total revenue in the first quarter of 2014) derives its revenues principally from four segments: implants, instruments, cases, and other products and services. The company provides implants for use in specific implant systems, mainly knee and hip implants. Orthopedic implants are used in reconstructive surgeries to replace or repair hips, knees, and other joints, primarily shoulders, ankles, and elbows.

Symmetry Medical also manufactures implant products for trauma, spine, and other implant systems. The company makes precision surgical instruments used in hip, knee, and shoulder reconstruction procedures, and in spinal, trauma, and other implant procedures. It also provides implant-specific and procedure-specific instruments.

The company produces plastic, metal, and hybrid cases to store, transport, and arrange surgical instruments and related implant systems for orthopedic device manufacturers. Dental cases are used in dental implant and general dental procedures. Other cases are used for arthroscopy, osteobiologic, endoscopy, cardiovascular, ophthalmology and diagnostic imaging as well as ear, nose, and throat procedures.

Symmetry Surgical business segment (20.4% of total revenue in the first quarter of 2014), headquartered in Nashville, Tennessee, was created in 2011. The segment arose from the integration of the Codman surgical instruments and Olsen Medical lines with the company's already existing hospital direct business, Specialty Surgical Instrumentation ("SSI").

Symmetry Surgical offers a broad range of reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products (vein strippers, SECTO dissectors, tonsil sponges and surgical marker pens), and sterilization containers. These products are typically used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices.


Symmetry Medical, Inc. (SMA): Read the Full Research Report
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

SYMMETRY MEDICL (SMA): Free Stock Analysis Report

To read this article on Zacks.com click here.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Stocks

Referenced Stocks: SMA

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

84,725,997
  • $6.69 ▼ 5.11%
68,180,500
  • $3.38 ▼ 1.74%
52,748,572
  • $99.02 ▲ 1.38%
40,996,811
  • $74.92 ▼ 0.36%
37,831,986
  • $15.50 ▼ 0.58%
34,013,720
  • $31.98 ▼ 4.31%
32,417,159
  • $25.59 ▼ 0.78%
31,985,971
  • $54.87 ▲ 1.20%
As of 7/28/2014, 04:05 PM